Rare diseases
Investigational molecules
Locations
11025 North Torrey Pines Road Suite 140, 92037-1030, United States
Inhibrx Biosciences Inc. focuses on oncology programs for adults with advanced or metastatic solid tumors, including broader tumour settings where disease control and progression outcomes are central clinical concerns. Its portfolio includes studies across multiple solid tumor types and treatment combinations.
Research activity in this area spans patients with difficult-to-treat malignancies and evaluation of therapeutic approaches intended to address tumour growth and disease progression.
Inhibrx Biosciences Inc. runs clinical trials in conditions such as Neoplasm, Squamous cell carcinoma of head and neck, Chondrosarcoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
BelgiumFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
